Why the study?
Atrial cardiomyopathy in HFpEF forms a bidirectional, mutually reinforcing feedback loop with ventricular dysfunction and atrial fibrillation, worsening outcomes.
Answers are grounded in this paper and cite their sources.
This review emphasizes the critical role of atrial cardiomyopathy and its bidirectional interaction with ventricular dysfunction in the pathophysiology and progression of HFpEF.
Heart failure with preserved ejection fraction (HFpEF) is a complex and heterogeneous condition with a distinct pathophysiology involving both systemic and cardiac dysfunction. Its impact extends beyond the left ventricle, notably to the atrial chambers where atrial abnormalities manifesting with structural, functional, and electrophysiologic abnormalities demonstrate a bidirectional relationship with impaired ventricular filling. These atrial changes create a pro-arrhythmic substrate, fostering both initiation and perpetuation of atrial fibrillation. Conversely, atrial disease, including atrial fibrillation, exacerbates HFpEF by promoting further pathologic remodeling, aggravating diastolic dysfunction, and elevating filling pressures. This bidirectional interaction establishes a mutually reinforcing feedback loop, which is associated with increased morbidity and mortality. In this review, we will highlight key aspects of atrial cardiomyopathy associated with HFpEF and explore their impact on HFpEF pathophysiology and treatment.
No takes yet. Share an insight, caveat, or question.
Haykal et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: